- Q4 2023 Achieve Life Sciences Inc Earnings Call TranscriptMar 28, 2024€4.06Earnings
- Q3 2023 Achieve Life Sciences Inc Earnings Call TranscriptNov 09, 2023€3.84 (+1.59%)Earnings
- Q2 2023 Achieve Life Sciences Inc Earnings Call TranscriptAug 15, 2023€4.64 (-1.28%)Earnings
- Achieve Life Sciences Inc at LD Micro Invitational Conference TranscriptJun 07, 2023
- Achieve Life Sciences Inc ORCA-3 Conference Call TranscriptMay 23, 2023
- Q1 2023 Achieve Life Sciences Inc Earnings Call TranscriptMay 09, 2023€7.85 (+3.29%)Earnings
- Achieve Life Sciences Inc Phase 2 ORCA-V1 Trial Results Call TranscriptApr 20, 2023
- Q4 2022 Achieve Life Sciences Inc Earnings Call TranscriptMar 16, 2023€4.18 (+0.38%)Earnings
- Q3 2022 Achieve Life Sciences Inc Earnings Call TranscriptNov 14, 2022€2.05 (+4.87%)Earnings
- Q2 2022 Achieve Life Sciences Inc Earnings Call TranscriptAug 11, 2022€4.91Earnings
- Achieve Life Sciences Inc Annual Shareholders Meeting TranscriptMay 31, 2022
- Q1 2022 Achieve Life Sciences Inc Earnings Call TranscriptMay 12, 2022€6.07 (-4.03%)Earnings
- Achieve Life Sciences Inc Clinical Development Update Call TranscriptApr 27, 2022
- Q4 2021 Achieve Life Sciences Inc Earnings Call TranscriptMar 10, 2022€5.8 (-4.13%)Earnings
- Achieve Life Sciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) TranscriptFeb 08, 2022
- Q2 2021 Achieve Life Sciences Inc Earnings Call TranscriptAug 12, 2021€6.2 (-3.88%)Earnings
- Q4 2020 Achieve Life Sciences Inc Earnings Call TranscriptMar 11, 2021€9.92 (+1.22%)Earnings
- Q2 2019 Achieve Life Sciences Inc Earnings Call TranscriptAug 08, 2019€32.8 (+9.33%)Earnings
Achieve Life Sciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Good day, and welcome to the second annual Winter Wonderland Best Ideas Conference. The next presenting company is Achieve Life Sciences. (Operator Instructions) I'd now like to turn the floor over to today's host, John Bencich, CEO of Achieve Life Sciences. Sir, the floor is yours.
Great. Thanks for the introduction, and thanks to everyone for joining us today. Before we get going, I'd just like to remind everyone that I may be making forward-looking statements as part of the presentation today. So I would refer everyone to our filings on sec.gov and the risk factors contained therein.
So here in Achieve Life Science, we're focused on the development and ultimately, the commercialization of a drug called cytisinicline as an aid for smoking cessation and treatment for nicotine addiction. And we have a really compelling product on our hands since, one that has a huge amount of historical data supporting the safety and efficacy of the product. There's been extensive research as part of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)